Skip to content
    Moore Strategic Ventures logo

    Moore Strategic Ventures

    New York, New York, United StatesFounded 2014
    moorestrategicventures.com
    Enterprise SoftwareFintechBiotech & Life SciencesAIClimate & Energy

    Moore Strategic Ventures is the venture capital and private investment vehicle of Louis M. Bacon, founder of Moore Capital Management. Based in New York, the firm provides flexible capital and long-term strategic support to high-growth businesses across sectors including enterprise software, fintech, AI, biotech, and energy.

    Deal activity increased 50% year-over-year (9 deals in the last 12 months). Average disclosed round size is $119.3M (across 117 rounds with reported amounts).

    Find people at Moore Strategic Ventures on Goldilocks AI

    Portfolio

    85

    Fund Size

    —

    Top Stage

    Series C

    Last 12 Mo

    9

    Team

    AF

    Alan Freedman

    Senior Managing Director

    JH

    James H. McIntyre

    Senior Managing Director

    GK

    Geordie Keelan

    Managing Director

    HH

    Hunter Horgan

    Managing Director

    JW

    Jessie Wong Harlin

    Managing Director - Special Investments

    DP

    Drew Podgorski

    Principal

    AT

    Anthony Terenzio

    Investor

    DK

    Dwight Keysor

    Chief Investment Officer

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    129 investments
    CompanyRoundAmountDate
    Plata logoPlataSeries C$405MApr 2026
    XFlow logoXFlowSeries A$16.6MFeb 2026
    Mirador logoMiradorSeries B$250MJan 2026
    Mirador Tx logoMirador TxSeries B$250MJan 2026
    Salmon logoSalmonUnknown$100MJan 2026
    Plata logoPlataUnknown—Dec 2025
    Forterra logoForterraGrowth—Nov 2025
    Elephas logoElephasSeries B$40MNov 2025
    Elephas logoElephasSeries B$40MNov 2025
    Shift5 logoShift5Series C$75MSep 2025
    JJocasta NeuroscienceSeries A$35MAug 2025
    JJocasta NeuroscienceUnknown$35MAug 2025
    Forterra logoForterraSeries C$238MMay 2025
    Plata logoPlataSeries A$160MMay 2025
    Utilidata logoUtilidataSeries C$60.3MApr 2025
    MMirador TherapeuticsUnknown$250MJan 2025
    Paramify logoParamifySeries A$12MJan 2025
    JJocasta NeuroscienceSeries A$35MJan 2025
    Mirador Tx logoMirador TxSeries B$250MJan 2025
    Second Front logoSecond FrontSeries C$70MSep 2024
    Salmon Group Ltd logoSalmon Group LtdSeries A$100MApr 2024
    TORL Biotherapeutics logoTORL BiotherapeuticsSeries B$158MApr 2024
    Mirador Tx logoMirador TxUnknown$400MMar 2024
    Simetrik logoSimetrikSeries B$55MFeb 2024
    Elephas logoElephasSeries C$55MJan 2024
    Page 1 of 6

    Top Co-Investors

    ARCH Venture Partners18 shared
    Andreessen Horowitz8 shared
    Hedosophia8 shared
    Baillie Gifford8 shared
    Franklin Templeton8 shared
    General Atlantic8 shared
    Salesforce Ventures7 shared
    Tiger Global Management, LLC7 shared
    India Quotient7 shared
    8VC6 shared
    Founders Fund6 shared
    Northpond Ventures6 shared
    Sands Capital6 shared
    Lightspeed Venture Partners6 shared
    Logos Capital6 shared
    Bedrock6 shared
    Valor Equity Partners6 shared
    General Catalyst5 shared
    Y Combinator5 shared
    True Ventures5 shared

    Last updated: 7 October 2026